Millipore Sigma Vibrant Logo
Attention: We have moved. Merck Millipore products are no longer available for purchase on MerckMillipore.com.Learn More

AB10605 Anti-ANGPTL4 (MID) Antibody

AB10605
100 µg  
Purchase on Sigma-Aldrich

Speciální nabídky

Přehled

Replacement Information

Speciální nabídky

Tabulka spec. kláve

Species ReactivityKey ApplicationsHostFormatAntibody Type
H, M, RWBRbPurifiedPolyclonal Antibody
Description
Catalogue NumberAB10605
Brand Family Chemicon®
Trade Name
  • Chemicon
DescriptionAnti-ANGPTL4 (MID) Antibody
Background InformationANGPTL4 (angiopoietin-like protein 4, hepatic fibrinogen/angiopoietin-related protein (HFARP), fasting-induced adipose factor (FIAF), PPARγ angiopoietin-related protein (PGAR)) is a secreted protein selectively expressed in adipose tissue, liver, and placent, that plays a variety of roles in vivo, ranging from adipogenesis to angiogenesis to carcinogenesis. Several transcription factors exert influence on ANGPTL4 transcription, including PPARα, PPARγ, and HIF 1α. PPARα and HIF 1α synergistically cause the activation of ANGPTL4 in cardiomyocytes; induction of ANGPTL4 in the heart inhibits lipoprotein-derived fatty acid delivery. As a transcriptional target of PPARγ, ANGPTL4 has been hypothesized to play a role in adipogenesis, insulin sensitivity, and energy metabolism. The expression of ANGPTL4 is also under nutritional and hormonal control. During fasting conditions, transcription of ANGPTL4 in both liver and adipose tissue is induced independently of PPARα1 While circulating levels of ANGPTL4 are increased in genetically obese mice, rodents fed a highfat diet demonstrate reduced circulating ANGPTL4 levels, suggesting that ANGPTL4 may be involved in response to the availability of nutrients. In endothelial cells, ANGPTL4 mRNA and protein levels increase in response to hypoxia. ANGPTL4 has been observed to induce a strong pro-angiogenic response independent of vascular endothelial growth factor (VEGF), and its expression has been described in hypoxic human tissues as well as a variety of cancers, including liposarcoma, hepatocellular carcinoma, and conventional renal cell carcinoma. Taken together, these findings suggest that ANGPTL4 may be involved in the mechanisms that compensate for ischemia by angiogenesis.
References
Product Information
FormatPurified
Presentation400 μL aliquot at a concentration of 0.25 mg/mL in phosphate buffered saline (pH 7.4) containing 0.1% sodium azide.
Quality LevelMQ100
Applications
ApplicationAnti-ANGPTL4 (MID) Antibody is an antibody against ANGPTL4 (MID) for use in WB.
Key Applications
  • Western Blotting
Application NotesWestern Blotting: 1-3 μg/mL
Biological Information
ImmunogenSynthetic peptide derived from an internal region of the human ANGTPL4 protein, which differs from rat and mouse by one and two conservative amino acid replacements, respectively.
CloneZMD.521
HostRabbit
SpecificityRecognizes ANGPTL4 (MID).
Species Reactivity
  • Human
  • Mouse
  • Rat
Species Reactivity NoteHuman, Mouse, Rat (positive controls: HepG2 and NGP96 cell lysates, mouse placenta and rat liver homogenates, serum-stimulated mouse 3T3-L1 embryo fibroblast lysates, and 2 week-old mouse brain homogenates).
Antibody TypePolyclonal Antibody
Entrez Gene Number
Entrez Gene SummaryThis gene is a member of the angiopoietin/angiopoietin-like gene family and encodes a glycosylated, secreted protein with a fibrinogen C-terminal domain. This gene is induced under hypoxic conditions in endothelial cells and is the target of peroxisome proliferation activators. The encoded protein is a serum hormone directly involved in regulating glucose homeostasis, lipid metabolism, and insulin sensitivity and also acts as an apoptosis survival factor for vascular endothelial cells. The encoded protein may play a role in several cancers and it also has been shown to prevent the metastatic process by inhibiting vascular activity as well as tumor cell motility and invasiveness. Decreased expression of this protein has been associated with type 2 diabetes. Alternatively spliced transcript variants encoding different isoforms have been described. This gene was previously referred to as ANGPTL2 but has been renamed ANGPTL4.
Gene Symbol
  • ANGPTL4
  • UNQ171/PRO197
  • HFARP
  • ANGPTL2
  • PSEC0166
  • PGAR
  • NL2
  • pp1158
  • ARP4
  • FIAF
Purification MethodImmunoAffinity Purified
UniProt Number
UniProt SummaryFUNCTION: SwissProt: Q9BY76 # Protein with hypoxia-induced expression in endothelial cells. May act as a regulator of angiogenesis and modulate tumorgenesis. Inhibits proliferation, migration, and tubule formation of endothelial cells and reduces vascular leakage. May exert a protective function on endothelial cells through an endocrine action. It is directly involved in regulating glucose homeostasis, lipid metabolism, and insulin sensitivity. In response to hypoxia, the unprocessed form of the protein accumulates in the subendothelial extracellular matrix (ECM). The matrix-associated and immobilized unprocessed form limits the formation of actin stress fibers and focal contacts in the adhering endothelial cells and inhibits their adhesion. It also decreases motility of endothelial cells and inhibits the sprouting and tube formation (By similarity).
SIZE: 406 amino acids; 45214 Da
SUBUNIT: Homooligomer. The homooligomer undergoes proteolytic processing to release its carboxyl fibrinogen-like domain, which circulates as a monomer. The homooligomer unprocessed form is able to interact with the extracellular matrix (By similarity).
SUBCELLULAR LOCATION: Secreted. Secreted, extracellular space, extracellular matrix (By similarity). Note=The unprocessed form interacts with the extracellular matrix. This may constitute a dynamic reservoir, a regulatory mechanism of the bioavailability of ANGPTL4 (By similarity).TISSUE SPECIFICITY: Expressed at high levels in the placenta, heart, liver, muscle, pancreas and lung but expressed poorly in the brain and kidney.
PTM: N-glycosylated.
DISEASE: SwissProt: Q9BY76 # Found to be highly expressed in the early stages of collagen-induced arthritis (CIA). & Serum levels of ANGPTL4 are significantly lower in patients with diabetes type 2 than those in healthy subjects, suggesting that decreased ANGPTL4 could be a causative factor of this disease. & Produced in ischemic tissues in conditions such as critical leg ischemia. In tumors, ANGPTL4 could be produced in the hypoxic areas surrounding necrotic regions. High levels could be produced in tumor cells of conventional renal cell carcinoma. This molecule therefore seems to be a marker of conventional renal cell carcinoma.
SIMILARITY: SwissProt: Q9BY76 ## Contains 1 fibrinogen C-terminal domain.
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Usage Statement
  • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Storage and Shipping Information
Storage ConditionsMaintain at -20°C in undiluted aliquots for up to 12 months. Avoid repeated freeze/thaw cycles.
Packaging Information
Material Size100 µg
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
Katalogové číslo GTIN
AB10605 04053252369650

Documentation

Anti-ANGPTL4 (MID) Antibody MSDS

Title

Safety Data Sheet (SDS) 

Anti-ANGPTL4 (MID) Antibody Certificates of Analysis

TitleLot Number
RABBIT ANTI-ANGPTL4 (MID) POLYCLONAL ANTIBODY - 2420384 2420384
RABBIT ANTI-ANGPTL4 (MID) - 3603053 3603053
RABBIT ANTI-ANGPTL4 (MID) - 3835232 3835232
RABBIT ANTI-ANGPTL4 (MID) - 3939229 3939229
RABBIT ANTI-ANGPTL4 (MID) - 3948179 3948179
RABBIT ANTI-ANGPTL4 (MID) -2585885 2585885
RABBIT ANTI-ANGPTL4 (MID) POLYCLONAL ANTIBODY 3089157
RABBIT ANTI-ANGPTL4 (MID) POLYCLONAL ANTIBODY 3143234
RABBIT ANTI-ANGPTL4 (MID) POLYCLONAL ANTIBODY - 2280825 2280825

References

Reference overviewPub Med ID
Characterization of the fasting-induced adipose factor FIAF, a novel peroxisome proliferator-activated receptor target gene
Kersten, S, et al
J Biol Chem, 275:28488-93 (2000)  1999

10862772 10862772
Molecular cloning and functional expression of mouse connexin40, a second gap junction gene preferentially expressed in lung.
Hennemann, H, et al.
J. Cell Biol., 117: 1299-310 (1992)  1992

Zobrazit abstrakt
1318884 1318884

Data Sheet

Title
RABBIT ANTI-ANGPTL4 (MID) POLYCLONAL ANTIBODY